Survivin and molecular pathogenesis of colorectal cancer

Paul Kim(Profectus Biosciences (United States)), Dario C. Altieri(The Wistar Institute), Janet Plescia(University of Massachusetts Chan Medical School), Hans Clevers(Hubrecht Institute for Developmental Biology and Stem Cell Research), Eric R. Fearon(University of Michigan)
The Lancet
July 1, 2003
10.1016/s0140-6736(03)13910-4
Cited by 322

Related Papers

Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
|Cell|2015|2.4k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
|Science|1989|2.1k
The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
|Cell|2002|2k
Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver
|Cell|2014|1.6k